DEA Issues Third Extension of Temporary Telemedicine Flexibilities
The U.S. Drug Enforcement Administration (DEA) has extended the temporary telemedicine flexibilities allowing providers to…
The U.S. Drug Enforcement Administration (DEA) has extended the temporary telemedicine flexibilities allowing providers to…
The Coalition for Health AI (CHAI), a group of stakeholders that collaborate to drive the…
On November 8, 2024, Aimed Alliance submitted feedback to the Maryland Prescription Drug Affordability Board…
Currently, Medicare coverage for anti-obesity medications is limited to indications for diabetes and cardiovascular disease.…
On October 10, 2024, the National AI Advisory Committee released its draft transition plan…
A recent survey by the National Community Pharmacists Association (NCPA) indicates that over 90 percent…
A recent survey of 227 patients examining patients’ experiences with alternative funding programs (AFP) found…
Join Aimed Alliance and HR.com for an upcoming webinar on December 4, 2024 at 3PM…
On October 18, 2024, Aimed Alliance sent a letter to the Maryland Legislative Policy Committee,…
On October 16, 2024, Aimed Alliance submitted a comment to Colorado’s PDAB regarding proposed changes…